The BCL-xL/BCL-2 Inhibitor Navitoclax Targets Myofibroblasts and Reduces Idiopathic Pulmonary Fibrosis (IPF) in Pre-Clinical Models
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE(2020)
关键词
idiopathic pulmonary fibrosis,myofibroblasts,inhibitor,pre-clinical
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要